rAAVrh74.MCK.GALGT2
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for rAAVrh74.MCK.GALGT2, covering 2022-04-25 to 2022-04-25. Get the full timeline:
Most recent: Clinical Trial Update: Gene Transfer Clinical Trial to Deliver rAAVrh74.MCK.GALGT2 for Duchenne Muscular Dystrophy [Phase 1, Phase 2]